Published in J Nephrol on December 07, 2009
Understanding by older patients of dialysis and conservative management for chronic kidney failure. Am J Kidney Dis (2014) 1.74
Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease. CMAJ (2012) 1.43
CKD in elderly patients managed without dialysis: survival, symptoms, and quality of life. Clin J Am Soc Nephrol (2015) 1.11
African American and non-African American patients' and families' decision making about renal replacement therapies. Qual Health Res (2012) 1.09
Renal replacement therapy in the elderly population. Clin J Am Soc Nephrol (2012) 1.01
Dialysis in the frail elderly--a current ethical problem, an impending ethical crisis. J Gen Intern Med (2013) 0.99
Opting out of dialysis - Exploring patients' decisions to forego dialysis in favour of conservative non-dialytic management for end-stage renal disease. Health Expect (2013) 0.87
Factors associated with initiation of chronic renal replacement therapy for patients with kidney failure. Clin J Am Soc Nephrol (2013) 0.80
The Full Spectrum of Clinical Ethical Issues in Kidney Failure. Findings of a Systematic Qualitative Review. PLoS One (2016) 0.76
PAlliative Care in chronic Kidney diSease: the PACKS study--quality of life, decision making, costs and impact on carers in people managed without dialysis. BMC Nephrol (2015) 0.75
Age-based disparities in end-of-life decisions in Belgium: a population-based death certificate survey. BMC Public Health (2012) 0.75
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (2010) 18.36
Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44
Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med (2012) 9.88
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int (2010) 9.25
Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med (2013) 7.98
Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation (2002) 7.25
Age and association of kidney measures with mortality and end-stage renal disease. JAMA (2012) 7.20
Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int (2004) 6.32
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26
Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int (2011) 6.01
Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med (2003) 5.47
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet (2012) 5.10
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (2012) 4.87
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet (2012) 4.75
Genetic loci influencing kidney function and chronic kidney disease. Nat Genet (2010) 3.75
Change in the estimated glomerular filtration rate over time and risk of all-cause mortality. Kidney Int (2013) 3.05
Routine use of the confusion assessment method for the intensive care unit: a multicenter study. Am J Respir Crit Care Med (2011) 2.97
Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA (2009) 2.85
Residual renal function at the start of dialysis and clinical outcomes. Nephrol Dial Transplant (2009) 2.69
Renal replacement therapy in children: data from 12 registries in Europe. Pediatr Nephrol (2003) 2.65
The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study. Nephrol Dial Transplant (2006) 2.50
Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort. Kidney Int (2010) 2.48
Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000). Kidney Int (2005) 2.44
Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients. Am J Kidney Dis (2011) 2.38
Microalbuminuria and risk of venous thromboembolism. JAMA (2009) 2.35
Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J (2013) 2.32
Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation (2004) 2.30
Patterns of functioning and predictive factors in children born moderately preterm or at term. Dev Med Child Neurol (2012) 2.28
Screening for albuminuria identifies individuals at increased renal risk. J Am Soc Nephrol (2009) 2.24
Comparison of different measures of urinary protein excretion for prediction of renal events. J Am Soc Nephrol (2010) 2.22
Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol (2013) 2.18
Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. Am J Epidemiol (2008) 2.09
Progress with the European Society for Paediatric Nephrology (ESPN)/ERA-EDTA Registry for children with established renal failure (ERF). Nephrol Dial Transplant (2009) 2.06
Urinary magnesium excretion and risk of hypertension: the prevention of renal and vascular end-stage disease study. Hypertension (2013) 2.03
Short-term change in kidney function and risk of end-stage renal disease. Nephrol Dial Transplant (2012) 2.01
When do we need competing risks methods for survival analysis in nephrology? Nephrol Dial Transplant (2013) 1.95
Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion. Nephrol Dial Transplant (2008) 1.89
Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general population. Atherosclerosis (2009) 1.88
Global differences in dialysis modality mix: the role of patient characteristics, macroeconomics and renal service indicators. Nephrol Dial Transplant (2013) 1.88
First morning voids are more reliable than spot urine samples to assess microalbuminuria. J Am Soc Nephrol (2008) 1.86
High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate. Eur Heart J (2012) 1.86
Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study. BMJ (2009) 1.84
Improving quality of care. A systematic review on how medical registries provide information feedback to health care providers. Int J Med Inform (2010) 1.84
A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis (2003) 1.82
Support for the global feasibility of the Ages and Stages Questionnaire as developmental screener. Early Hum Dev (2009) 1.79
Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment. Clin J Am Soc Nephrol (2012) 1.78
The effect of joint exposures: examining the presence of interaction. Kidney Int (2009) 1.78
Association of cognitive function with albuminuria and eGFR in the general population. Clin J Am Soc Nephrol (2011) 1.77
An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study. J Clin Endocrinol Metab (2006) 1.75
Cardiovascular risk factors are differently associated with urinary albumin excretion in men and women. J Am Soc Nephrol (2003) 1.75
Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study. Nephrol Dial Transplant (2009) 1.74
An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population. Kidney Int Suppl (2004) 1.71
Early identification of risk factors for refractory secondary hyperparathyroidism in patients with long-term renal replacement therapy. Nephrol Dial Transplant (2004) 1.69
Development and validation of a general population renal risk score. Clin J Am Soc Nephrol (2011) 1.69
Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet (2012) 1.69
Copeptin, a surrogate marker of vasopressin, is associated with accelerated renal function decline in renal transplant recipients. Transplantation (2009) 1.69
The case for using albuminuria in staging chronic kidney disease. J Am Soc Nephrol (2009) 1.67
Sodium excretion and risk of developing coronary heart disease. Circulation (2014) 1.67
Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant (2012) 1.67
Fact or fiction of the epidemic of chronic kidney disease--let us not squabble about estimated GFR only, but also focus on albuminuria. Nephrol Dial Transplant (2008) 1.61
Demographics of blood pressure and hypertension in children on renal replacement therapy in Europe. Kidney Int (2011) 1.61
The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population. Kidney Int Suppl (2005) 1.61
Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts. Circulation (2012) 1.59
Hypertension and road traffic noise exposure. J Occup Environ Med (2007) 1.59
Changes in left ventricular diastolic function during hemodialysis sessions. Am J Kidney Dis (2013) 1.58
Screening for chronic kidney disease: where does Europe go? Clin J Am Soc Nephrol (2008) 1.56
Survival analysis: time-dependent effects and time-varying risk factors. Kidney Int (2008) 1.56
Effect of a multifaceted performance feedback strategy on length of stay compared with benchmark reports alone: a cluster randomized trial in intensive care*. Crit Care Med (2013) 1.56
Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999. Nephrol Dial Transplant (2003) 1.56
Urinary and plasma magnesium and risk of ischemic heart disease. Am J Clin Nutr (2013) 1.54
Dual renin-angiotensin system blockade at optimal doses for proteinuria. Kidney Int (2002) 1.53
Comparison of the yield of different screening approaches to detect chronic kidney disease. Nephrol Dial Transplant (2010) 1.52
Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney Int (2005) 1.51
Impact of statins in microalbuminuric subjects with the metabolic syndrome: a substudy of the PREVEND Intervention Trial. Eur Heart J (2005) 1.50
Global variation in renal replacement therapy for end-stage renal disease. Nephrol Dial Transplant (2011) 1.50